Usually, the heavier the person, the greater the percentage of weight lost comes from fat
Approved by the FDA specifically for long-term weight management, this oral medication offers an alternative to the injectable form previously limited to managing type 2 diabetes under the brand Rybelsus
Lenmeldy is the first FDA-approved gene therapy for MLD, which is caused by a deficiency of the arylsulfatase A (ARSA) enzyme, a state that leads to a buildup of fatty substances in the cells
A Virta Health paper, yet to be released, shows a safe off-ramp may be possible, as hemoglobin A1c and body weight measured 12 months after de-prescription did not significantly differ between patients that continued GLP-1 usage and those that did not
Doron Stember, who has led our team as the Chief Medical Officer for Fountain for 2+ years and has seen over 1,000 patients
While laboratory studies provide insights into peptide activity, these observations remain under investigation and should not be interpreted as confirmed therapeutic effects